Category: Food & Drug Administration (FDA)Syndicate content

CorMatrix lands FDA win, touts 1st human implant of CanGaroo surgical pouch

August 28, 2014 by Arezu Sarvestani

CorMatrix secure FDA clearance for its CanGaroo ECM envelope for use with implantable cardiac devices and touts 1st human use in a patient at Ohio's Cleveland Clinic.

CorMatrix lands FDA win, touts 1st human implant of CanGaroo surgical evelope

Georgia medical device maker CorMatrix touted an FDA win this month, landing regulatory clearance for its CanGaroo surgical envelope for securing implantable cardiac devices.

Press Release: CorMatrix reports FDA clearance of CorMatrix CanGaroo ECM Envelope

August 28, 2014 by MassDevice

Press Release: CorMatrix reports FDA clearance of CorMatrix CanGaroo ECM Envelope

Roswell, Georgia – CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix CanGaroo ECM Envelope for use with cardiac implantable electronic devices (CIED's) including pacemakers and implantable cardioverter defibrillators (ICD's).

DePuy Synthes gets FDA's highest-risk warning after 15 complaints

August 27, 2014 by Arezu Sarvestani

The FDA puts its highest-risk Class I label on the recall of DePuy Synthes' jaw stabilizing system over a defect that may result in injury or death in infants.

DePuy Synthes recalls orthopedic implant, gets FDA's highest-risk warning

FDA regulators put their highest-risk Class I label on the recall of DePuy Synthes' Craniomaxillofacial Distraction System after the company reported 15 injuries associated with the jaw implant.

Diabetes: Nipro Dx boosts manufacturing following FDA wins for blood glucose monitors

August 25, 2014 by Arezu Sarvestani

Florida-based diabetes devices maker Nipro Diagnostics lands FDA clearance for 2 new blood glucose monitors and boosts its manufacturing capabilities ahead of a Q4 2014 launch.

Diabetes: Nipro Dx boosts manufacturing following FDA wins for blood glucose monitors

Diabetes company Nipro Diagnostics touted FDA wins for a pair of new blood glucose monitors for use in home and professional settings, saying that the device maker will look to boost its manufacturing capabilities ahead of a late 2014 launch.

Press Release: Nipro Diagnostics, Inc. announces FDA clearance of its newest blood glucose monitoring systems

August 25, 2014 by MassDevice

Nipro Diagnostics, Inc. announces FDA clearance of its newest blood glucose monitoring systems, True Metrix and True Metrix Pro, and expansion of manufacturing in the USA

Press Release: Nipro Diagnostics, Inc. announces FDA clearance of its newest blood glucose monitoring systems

FORT LAUDERDALE, Fla. – Nipro Diagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared its True Metrix Self-Monitoring blood glucose system and the True Metrix Pro Professional Monitoring blood glucose system.

Medtronic's personalized pacemaker wins FDA approval

August 25, 2014 by Arezu Sarvestani

FDA regulators approve Medtronic's new Viva CRT-P adaptive cardiac pacemaker for treatment of heart failure or atrioventricular block.

Medtronic's personalized pacemaker wins FDA approval

Medtronic (NYSE:MDT) won FDA approval for its Viva CRT-P cardiac resynchronization therapy-pacemaker, which features proprietary software to adjust its pacing parameters to a patient's heart rhythms minute-by-minute.

Press Release: Medtronic Viva cardiac resynchronization therapy-pacemaker now available in U.S.

August 25, 2014 by MassDevice

AdaptivCRT algorithm customizes therapy for heart failure patients and improves their response rates.

Press Release: Medtronic Viva cardiac resynchronization therapy-pacemaker now available in U.S.

MINNEAPOLIS - Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P, for indicated patients with heart failure or atrioventricular (AV) block.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp